BBNX insider transactions

Chief Medical Officer Russell Steven Jon sold $30,069 worth of shares (1,025 units at $29.34), decreasing direct ownership by 0.57% to 178,071 units (SEC Form 4)

Chief Commercial Officer Hopman Mark sold $88,304 worth of shares (2,917 units at $30.27), decreasing direct ownership by 2% to 136,216 units (SEC Form 4)

Amendment: SEC Form 4 filed by Chief Commercial Officer Hopman Mark

Amendment: SEC Form 4 filed by President & CEO Saint Sean

Amendment: SEC Form 4 filed by Chief Medical Officer Russell Steven Jon

Amendment: SEC Form 4 filed by Chief Product Officer Mensinger Mike

Amendment: SEC Form 4 filed by Chief Financial Officer Feider Stephen

Chief Commercial Officer Hopman Mark sold $4,084 worth of shares (353 units at $11.57), decreasing direct ownership by 0.25% to 139,133 units (SEC Form 4)

Chief Medical Officer Russell Steven Jon was granted 109,105 shares and sold $12,683 worth of shares (1,026 units at $12.36), increasing direct ownership by 152% to 179,096 units (SEC Form 4)

President & CEO Saint Sean was granted 343,269 shares and sold $41,832 worth of shares (3,384 units at $12.36), increasing direct ownership by 347% to 437,809 units (SEC Form 4)

Chief Commercial Officer Hopman Mark was granted 109,105 shares and sold $10,310 worth of shares (834 units at $12.36), increasing direct ownership by 347% to 139,486 units (SEC Form 4)

Chief Financial Officer Feider Stephen was granted 131,543 shares and sold $17,652 worth of shares (1,428 units at $12.36), increasing direct ownership by 305% to 172,729 units (SEC Form 4)

Chief Product Officer Mensinger Mike was granted 109,105 shares and sold $13,153 worth of shares (1,064 units at $12.36), increasing direct ownership by 134% to 188,793 units (SEC Form 4)

Director Michel Gerard J was granted 3,997 shares, increasing direct ownership by 32% to 16,544 units (SEC Form 4)

Director Palasis Maria was granted 3,997 shares, increasing direct ownership by 47% to 12,432 units (SEC Form 4)

Director Carney Sean was granted 3,997 shares, increasing direct ownership by 36% to 15,244 units (SEC Form 4)

Director Lezack Adam was granted 3,997 shares, increasing direct ownership by 47% to 12,432 units (SEC Form 4)

Director Dearen Danny L. was granted 3,997 shares, increasing direct ownership by 36% to 15,244 units (SEC Form 4)

Director Jones Christy was granted 3,997 shares, increasing direct ownership by 36% to 15,244 units (SEC Form 4)

Chief Product Officer Mensinger Mike sold $66,221 worth of shares (2,200 units at $30.10), decreasing direct ownership by 3% to 80,752 units (SEC Form 4)

Chief Product Officer Mensinger Mike sold $230,950 worth of shares (7,800 units at $29.61), decreasing direct ownership by 9% to 82,952 units (SEC Form 4)

Chief Financial Officer Feider Stephen exercised 20,000 shares at a strike of $5.10 and sold $590,680 worth of shares (20,000 units at $29.53) (SEC Form 4)

Chief Product Officer Mensinger Mike sold $31,184 worth of shares (1,063 units at $29.34), decreasing direct ownership by 1% to 90,752 units (SEC Form 4)

President & CEO Saint Sean sold $96,163 worth of shares (3,278 units at $29.34), decreasing direct ownership by 3% to 97,924 units (SEC Form 4)

Chief Financial Officer Feider Stephen sold $41,862 worth of shares (1,427 units at $29.34), decreasing direct ownership by 3% to 42,614 units (SEC Form 4)

SEC Form 4 filed by Beta Bionics Inc.

Director Lezack Adam sold $41,543 worth of shares (1,406 units at $29.55), decreasing direct ownership by 14% to 8,435 units (SEC Form 4)

Director Lezack Adam sold $37,780 worth of shares (1,406 units at $26.87), decreasing direct ownership by 13% to 9,841 units (SEC Form 4)

Director Palasis Maria sold $37,834 worth of shares (1,406 units at $26.91), decreasing direct ownership by 13% to 9,841 units (SEC Form 4)

Chief Financial Officer Feider Stephen exercised 4,982 shares at a strike of $5.10 and sold $108,076 worth of shares (4,982 units at $21.69) (SEC Form 4)

Chief Financial Officer Feider Stephen exercised 15,018 shares at a strike of $5.10 and sold $311,806 worth of shares (15,018 units at $20.76) (SEC Form 4)

Chief Financial Officer Feider Stephen exercised 9,900 shares at a strike of $5.10 and sold $209,151 worth of shares (9,900 units at $21.13) (SEC Form 4)

Chief Commercial Officer Hopman Mark sold $370,837 worth of shares (18,229 units at $20.34) and exercised 16,160 shares at a strike of $5.10, decreasing direct ownership by 6% to 31,215 units (SEC Form 4)

Chief Financial Officer Feider Stephen exercised 100 shares at a strike of $5.10 and sold $2,100 worth of shares (100 units at $21.00) (SEC Form 4)

President & CEO Saint Sean sold $63,361 worth of shares (3,359 units at $18.86), decreasing direct ownership by 3% to 101,202 units (SEC Form 4)

Chief Commercial Officer Hopman Mark sold $15,996 worth of shares (848 units at $18.86), decreasing direct ownership by 2% to 33,284 units (SEC Form 4)

Chief Financial Officer Feider Stephen sold $27,578 worth of shares (1,462 units at $18.86), decreasing direct ownership by 3% to 44,041 units (SEC Form 4)

Chief Product Officer Mensinger Mike sold $20,542 worth of shares (1,089 units at $18.86), decreasing direct ownership by 1% to 91,815 units (SEC Form 4)

Chief Medical Officer Russell Steven Jon sold $19,146 worth of shares (1,015 units at $18.86), decreasing direct ownership by 1% to 71,017 units (SEC Form 4)

Chief Financial Officer Feider Stephen sold $75,083 worth of shares (4,413 units at $17.01) and exercised 4,413 shares at a strike of $5.10 (SEC Form 4)

Chief Financial Officer Feider Stephen exercised 5,587 shares at a strike of $5.10 and sold $95,172 worth of shares (5,587 units at $17.03) (SEC Form 4)

Chief Commercial Officer Hopman Mark exercised 16,158 shares at a strike of $5.10 and sold $268,376 worth of shares (16,158 units at $16.61) (SEC Form 4)

Chief Medical Officer Russell Steven Jon sold $18,588 worth of shares (1,039 units at $17.89), decreasing direct ownership by 1% to 72,032 units (SEC Form 4)

Chief Product Officer Mensinger Mike sold $19,948 worth of shares (1,115 units at $17.89), decreasing direct ownership by 1% to 92,904 units (SEC Form 4)

Chief Commercial Officer Hopman Mark sold $15,529 worth of shares (868 units at $17.89), decreasing direct ownership by 2% to 34,132 units (SEC Form 4)

President & CEO Saint Sean sold $61,526 worth of shares (3,439 units at $17.89), decreasing direct ownership by 3% to 104,561 units (SEC Form 4)

Chief Financial Officer Feider Stephen sold $26,783 worth of shares (1,497 units at $17.89), decreasing direct ownership by 3% to 45,503 units (SEC Form 4)

Director Michel Gerard J was granted 12,547 shares (SEC Form 4)

SEC Form 3 filed by new insider Michel Gerard J

Director Lezack Adam was granted 11,247 shares (SEC Form 4)

Director Jones Christy was granted 11,247 shares (SEC Form 4)

Director Palasis Maria was granted 11,247 shares (SEC Form 4)

Director Dearen Danny L. was granted 11,247 shares (SEC Form 4)

Director Carney Sean was granted 11,247 shares (SEC Form 4)

Chief Financial Officer Feider Stephen was granted 47,000 shares (SEC Form 4)

Chief Commercial Officer Hopman Mark was granted 35,000 shares (SEC Form 4)

President & CEO Saint Sean was granted 108,000 shares (SEC Form 4)

Chief Product Officer Mensinger Mike was granted 35,000 shares, increasing direct ownership by 59% to 94,019 units (SEC Form 4)

Chief Medical Officer Russell Steven Jon was granted 35,000 shares, increasing direct ownership by 92% to 73,071 units (SEC Form 4)

SEC Form 4 filed by President & CEO Saint Sean